Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis

Erik I. Tucker, Norah G. Verbout, Philberta Y. Leung, Sawan Hurst, Owen J. T. McCarty, David Gailani, András Gruber

Blood (2012) 119 (20): 4762–4768.

https://doi.org/10.1182/blood-2011-10-386185

Published: 2012

Journal Articles

Apple Domain-Specific Anti-Factor XI Antibodies Inhibit Venous-Type Thrombosis with Improved Hemostatic Safety Profiles Compared to Enoxaparin in Primates

Erik I. Tucker, PhD, Ulla M Marzec, MS, Philberta Y Leung, PhD, Stephen R Hanson, PhD, Prof., Norah G Verbout, PhD, Sawan Hurst, MS, Owen J.T. McCarty, PhD, David Gailani, MD, Andras Gruber, MD

Blood (2011) 118 (21): 1173.

https://doi.org/10.1182/blood.V118.21.1173.1173

Published: 2011

Journal Articles

Factor XI Inhibitor Antibody Treatment Improves Survival In a Murine Polymicrobial Sepsis Model

Erik I Tucker, PhD, Melani Helm, BS, Owen JT McCarty, PhD, Sawan Hurst, MS, David Gailani, MD, Andras Gruber, MD

Blood (2010) 116 (21): 820.

https://doi.org/10.1182/blood.V116.21.820.820

Published: 2010

Journal Articles

Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI

Erik I. Tucker, Ulla M. Marzec, Tara C. White, Sawan Hurst, Sandra Rugonyi, Owen J. T. McCarty, David Gailani, András Gruber, Stephen R. Hanson

Blood (2009) 113 (4): 936–944.

https://doi.org/10.1182/blood-2008-06-163675

Published: 2009

Journal Articles

Moderate Pharmacological Platelet Count Reduction Limits Thrombus Formation without Hemostatic Impairment in Primates

Erik I Tucker, Ulla M Marzec, Sawan Hurst, András Gruber, MD, Stephen R Hanson, PhD

Blood (2008) 112 (11): 1033.

https://doi.org/10.1182/blood.V112.11.1033.1033

Published: 2008

Journal Articles

Thrombomodulin-Dependent Protein C Activator Treatment Improves the Short-Term Outcome of Experimental Ischemic Stroke in Mice.

Andras Gruber, MD, Patricia D. Hurn, PhD, Sawan Hurst, BS, Leslie Bush, MS, Ulla M. Marzec, MS, Erik Tucker, BS, Stephen R. Hanson, PhD, Enrico Di Cera, MD

Blood (2006) 108 (11): 895.

https://doi.org/10.1182/blood.V108.11.895.895

Published: 2006

NARROW

Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis

Apple Domain-Specific Anti-Factor XI Antibodies Inhibit Venous-Type Thrombosis with Improved Hemostatic Safety Profiles Compared to Enoxaparin in Primates

Factor XI Inhibitor Antibody Treatment Improves Survival In a Murine Polymicrobial Sepsis Model

Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI

Moderate Pharmacological Platelet Count Reduction Limits Thrombus Formation without Hemostatic Impairment in Primates

Thrombomodulin-Dependent Protein C Activator Treatment Improves the Short-Term Outcome of Experimental Ischemic Stroke in Mice.

Email alerts

ASH Publications

American Society of Hematology

Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis

Apple Domain-Specific Anti-Factor XI Antibodies Inhibit Venous-Type Thrombosis with Improved Hemostatic Safety Profiles Compared to Enoxaparin in Primates

Factor XI Inhibitor Antibody Treatment Improves Survival In a Murine Polymicrobial Sepsis Model

Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI

Moderate Pharmacological Platelet Count Reduction Limits Thrombus Formation without Hemostatic Impairment in Primates

Thrombomodulin-Dependent Protein C Activator Treatment Improves the Short-Term Outcome of Experimental Ischemic Stroke in Mice.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only